Genistein reverses diminished t-cell signal transduction, induced by post-menopausal estrogen levels

American Journal of Reproductive Immunology

Volumn 61, Issue 1, 2009, Pages 26-33

  Parry, J Preston ^a   Taylor, Douglas D ^a   Nakajima, Steven T ^a   Gercel Taylor, Cicek ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Estrogen deficiency; Genistein; Signal transduction; T cell

Indexed keywords

CD3 ANTIGEN; ESTRADIOL; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; JANUS KINASE 3; MESSENGER RNA;

AGING; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANTIGENS, CD3; ESTROGENS; FEMALE; GENISTEIN; HUMANS; INTERLEUKIN-2; JANUS KINASE 3; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NF-KAPPA B; POSTMENOPAUSE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 57749174886     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00658.x     Document Type: Article

References (35)

1. Franceschi C, BonaTè M, Valensin S: Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000; 18:1717-1720.
2. Linton PJ, Lustgarten JL Thoman M: T cell function in the aged: lessons learned from animal models. Clin Appl Immunol Rev 2006; 6:73-97.
3. Wick G, Grubeck-LoePenstein B: The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp Gerontol 1997; 32:401-413.
4. Quadri RA, Plastre O, Phelouzat MA, Arbogast A, Proust JJ: Age-related tyrosine-specific protein phosphorylation defect in human T lymphocytes activated through CD3, CD4, CD8 or the IL-2 receptor. Mech Ageing Dev 1996; 88:125-138.
5. Miller RA, Garcia G, Kirk CJ, Witkowski JM: Early activation defects in T lymphocytes from aged mice. Immunol Rev 1997; 160:79-90.
6. Pahlavani MAE T cell signaling: effect of age. Front Biosci 1998; 3:1120-1133.
7. Whisler RL, Karanfilov CI, Newhouse YG, Fox CC, Lakshanan RR, Liu B: Phosphorylation and coupling of ζ-chains to activated T-cell receptor (TCR)/CD3 complexes from peripheral blood T-cells of elderly humans. Mech Ageing Dev 1998; 105:115-135.
8. Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, Witkowski J, Fulbright J, Weyand CM, Goronzy JJ: The influence of age on T cell generation and TCR diversity. J Immunol 2005; 174:7446-7452.
9. Weng NP: Aging of the Hmmune system: how much can the adaptive immune system adapt? Immunity 2006; 24:495-499.
10. Shi J, Miller RA: Tyrosine-specific protein phosphorylation in response to anti-CD3 antibody is diminished in old mice. J Gerontol 1992; 7:B147-B153.
11. Murasko DM, Weiner P, Kaye D: Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin Exp Immunol 1987; 70:440-448.
12. Nagel JE, Chopra RK, Chrest FJ, McCoy MT, Schneider EL, Holbrook NJ, Adler WH: Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J Clin Invest 1988; 81:1096-1102.
13. Kahlke V, Angele MK, Ayala A, Schwacha MG, Cioffi WG, Bland KI, Chaudry H: Immune dysfunction following trauma-hemIrrhage: influence of gender and age. Cytokine 2000; 12:69-77.
14. De la Fuente M, Baeza I, Guayerbas N, Alvarez P, Alvarado C: Changes with aging in several leukocyte functions of male and female rats. Biogerontology 2004; 5:389-400.
15. Giglio T, Imro MA, Filaci G, Scudeletti M, Puppo F, De Cecco L, Indiveri F, Costantini S: Immune cell circulating subsets are affected by gonadal function. Life Sci 1994; 54:1305-1312.
16. Kumru S, Godekmerdan A, Ytlmaz B: Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J Reprod Immunol 2004; 63:31-38.
17. Rossow JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SAA, Howard BV, Johnson KC, Kotchen JM, Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.
18. Teede HJ, Dalais FS, Kotsopoulos D, McGrath BP, Malan E, Gan TE, Peverill RE: Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women. J Clin Endocrinol Metab 2005; 90:1936-1941.
19. Alexandrakis MG, Kyriakou DS, Kempuraj D, Huang M, Boucher W, Seretakis D, Theoharides TC: The isoflavone genistein inhibits proliferation and increases histamine content in human leukemic mast cells. Allergy Asthma Proc 2003; 24:373-377.
20. Sosroseno W, Bird PS, Seymour GJ: Intracellular proteins involved in Porphyromonas gingivalis - induced opsonophagocytic activities of a murine macrophage cell line (RAW264.7 cells). J Microbiol Immunol Infect 2003; 36:229-235.
21. Huang AJ, Ettinger B, Vittinghoff E, Ensrud KE, Johnson KC, Cummings SR: Endogenous estrogen levels and the effects of ultra-low-dose transdermal estradiol therapy on bone turnover and BMD in postmenopausal women. J Bone Miner Res 2007; 22:1791-1797.
22. Detti L, Saed GM, Jiang ZL, Kruger ML, Diamond MP: The effect of estradiol on the expression of estrogen, progesterone, androgen, and prolactin receptors in human peritoneal fibroblasts. J Assist Reprod Genet 2008; 25:245-250.
23. Adlercretuz H, Markkanen H, Watanabe S: Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342:1209-1210.
24. Irvine CH, Shand N, Fitzpatrick MG, Alexander SL: Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas. Am J Clin Nutr 1998; 68:1462S-1465S.
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
26. Brown R, Clugston C, Burns P, Edlin A, Vasey P, Vojtesek B, Kaye SB: Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int J Cancer 1993; 55:678-684.
27. Kamada M, Irahara M, Maegawa M, Ohmoto Y, Takeji T, Yasui T, Aono T: Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am J Obstet Gynecol 2001; 184:309-313.
28. Juby AG, Davis P: Prevalence and disease associations of certain autoantibodies in elderly patients. Clin Invest Med 1998; 21:4-11.
29. Rogers A, Eastell R: Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood. J Bone Miner Res 1998; 13:1577-1586.
30. Chakravarti B, Abraham GN: Aging and T-cell-mediated immunity. Mech Ageing Dev 1999; 108:183-206.
31. Porter VR, Greendale GA, Schocken M, Zhu X, Effros RB: Immune effects of hormone replacement therapy in post-menopausal women. Exp Gerontol 2001; 36:311-326.
32. Marriott I, Huet-Hudson YM: Sexual dimorphism in innate immune responses to infectious organisms. Immunol Rev 2006; 34:177-192.
33. Borrás C, Gambini J, Gómez-Cabrera MC, Sastre J, Pallardo FV, Mann GE, VinãJ: Genistein, a soy isoflavone, upregulates expression of antioxidant genes: Involvement of estrogen receptors, ERK1/ 2, and NFκB. FASEB J 2006; 20:E1476-E1481.
34. Beery TA: Sex differences in infection and sepsis. Crit Care Nurs Clin North Am 2003; 15:55-62.
35. Kammer GM, Tsokos GC: Emerging concepts of the molecular basis for estrogen effects on T lymphocytes in systemic lupus erythematosus. Clin Immunol Immunopathol 1998; 89:192-195.